SCHEMBL24112628

SCHEMBL24112628

CC(=O)OC(C)(C)c1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 3/20 0.40
SCN9A Q15858 3/20 0.40
PKM P14618 1/20 0.40
SLC6A2 P23975 2/20 0.39
CHRNA1 P02708 1/20 0.39
CHRNG P07510 1/20 0.39
ITGA5 P08648 1/20 0.39
CHRNB1 P11230 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
SLC6A4 P31645 1/20 0.39
CHRNA3 P32297 1/20 0.39
CYP2C19 P33261 1/20 0.39
HRH1 P35367 1/20 0.39
CHRNA7 P36544 1/20 0.39
OPRK1 P41145 1/20 0.39
CHRNA4 P43681 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CHRND Q07001 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305401 0.87 CYP3A4 (0.41) CYP2C19ALDH1A1ALOX15LMNAMAPT
SCHEMBL24019664 0.85 SLC6A2 (0.42) SCN5ASCN9APKMSLC6A2CHRNA1
SCHEMBL4189746 0.82 RXRA (0.47) CYP2C19KIF11ALDH1A1ALOX15LMNA
SCHEMBL24112745 0.82 HPGD (0.40) SCN5ASCN9APKMSLC6A2CHRNA1
SCHEMBL25769444 0.82 SCN5A (0.44) SCN5ASCN9APKMSLC6A2CHRNA1
SCHEMBL26059368 0.81 CYP3A4 (0.53) CYP2C19KIF11ALDH1A1PARP1LMNA
SCHEMBL24740445 0.80 SLC6A2 (0.40) SCN5ASCN9APKMSLC6A2CHRNA1
SCHEMBL25563995 0.79 KCNN4 (0.50) PARP1NPC1RAB9AMAOBHTT
SCHEMBL25564023 0.79 CES2 (0.49) CYP2C19ALDH1A1SMN1; SMN2RAB9AMAOB
SCHEMBL24019745 0.79 HPGD (0.43) SLC6A2CHRNA1CHRNGITGA5CHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021252644-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2021-12-16 WO disclosed